Emily M. Pang

690 total citations
20 papers, 544 citations indexed

About

Emily M. Pang is a scholar working on Pediatrics, Perinatology and Child Health, Hematology and Molecular Biology. According to data from OpenAlex, Emily M. Pang has authored 20 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 5 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Emily M. Pang's work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Emily M. Pang is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Emily M. Pang collaborates with scholars based in United States, Canada and United Kingdom. Emily M. Pang's co-authors include Xiaoyan Jiang, Ashley Ringrose, Youwen Zhou, Andrew P. Weng, Ann Lin, Irene Li, Xiaojiang Li, Connie J. Eaves, Allen Eaves and Karen Lambie and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biophysical Journal.

In The Last Decade

Emily M. Pang

19 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily M. Pang United States 10 262 150 135 73 61 20 544
Alexander Gural Israel 18 313 1.2× 328 2.2× 111 0.8× 136 1.9× 34 0.6× 48 885
Petros Papadopoulos Greece 14 150 0.6× 266 1.8× 130 1.0× 60 0.8× 41 0.7× 33 676
Francis Lacombe France 14 287 1.1× 190 1.3× 162 1.2× 141 1.9× 36 0.6× 35 653
Cecilia Fu United States 16 190 0.7× 404 2.7× 69 0.5× 219 3.0× 49 0.8× 32 945
Eva Norström Sweden 17 512 2.0× 201 1.3× 201 1.5× 31 0.4× 26 0.4× 31 857
Y. Ravindranath United States 14 266 1.0× 183 1.2× 83 0.6× 140 1.9× 51 0.8× 25 625
Ahmad Ahmadzadeh Iran 15 174 0.7× 388 2.6× 147 1.1× 230 3.2× 29 0.5× 67 805
Mohcine Bennani Mechita Morocco 13 87 0.3× 109 0.7× 96 0.7× 60 0.8× 25 0.4× 36 381

Countries citing papers authored by Emily M. Pang

Since Specialization
Citations

This map shows the geographic impact of Emily M. Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily M. Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily M. Pang more than expected).

Fields of papers citing papers by Emily M. Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily M. Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily M. Pang. The network helps show where Emily M. Pang may publish in the future.

Co-authorship network of co-authors of Emily M. Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Emily M. Pang. A scholar is included among the top collaborators of Emily M. Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily M. Pang. Emily M. Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Villacampa, Guillermo, Clara Martínez-Vila, Xavier González, et al.. (2025). 195P Health-related quality of life outcomes in SOLTI VALENTINE: A trial of neoadjuvant HER3-DXd +/- letrozole for high-risk hormone receptor positive/HER2-negative early breast cancer. ESMO Open. 10. 104749–104749. 1 indexed citations
3.
Smith, Stephanie M., Catherine Benedict, Emily M. Pang, et al.. (2023). A qualitative study of childhood cancer families’ post‐treatment needs and the impact of a community‐based organization in a rural, socioeconomically disadvantaged, majority Hispanic/Latino region. Pediatric Blood & Cancer. 71(2). e30798–e30798. 7 indexed citations
4.
Pang, Emily M., Olga Saynina, Lidia Schapira, et al.. (2023). Cancer center-based follow-up among pediatric and adolescent/young adult cancer survivors: the role of a community-based organization and the social determinants of health. Journal of Cancer Survivorship. 19(1). 242–252. 5 indexed citations
5.
Pang, Emily M., et al.. (2023). Evaluating Epidemiologic Trends and Variations in NICU Admissions in California, 2008 to 2018. Hospital Pediatrics. 13(11). 976–983. 2 indexed citations
6.
Sun, Beatrice J., Emily M. Pang, & Byrne Lee. (2023). Interpersonal concerns of young adult surgical oncology patients with advanced cancer diagnoses: A mixed methods study.. Journal of Clinical Oncology. 41(16_suppl). e24225–e24225. 1 indexed citations
7.
Murphy, Colin, Eric Mou, Emily M. Pang, et al.. (2021). A randomized study of a best practice alert for platelet transfusions. Vox Sanguinis. 117(1). 87–93. 4 indexed citations
8.
Pang, Emily M., et al.. (2021). Advancing Health Equity by Translating Lessons Learned from NICU Family Visitations During the COVID-19 Pandemic. NeoReviews. 22(1). e1–e6. 14 indexed citations
9.
Liu, Jessica, et al.. (2021). Evaluating Care in Safety Net Hospitals: Clinical Outcomes and Neonatal Intensive Care Unit Quality of Care in California. The Journal of Pediatrics. 243. 99–106.e3. 8 indexed citations
10.
Pang, Emily M., et al.. (2021). How is mobile health technology transforming physician–nurse collaboration?. Internal Medicine Journal. 51(9). 1522–1525. 4 indexed citations
11.
Chang, Julie, Emily M. Pang, Kolade Adebowale, Katrina M. Wisdom, & Ovijit Chaudhuri. (2020). Increased Stiffness Inhibits Invadopodia Formation and Cell Migration in 3D. Biophysical Journal. 119(4). 726–736. 34 indexed citations
12.
Ho, Han Kiat, Emily M. Pang, Csaba Szántai-Kis, et al.. (2013). Developing FGFR4 Inhibitors As Potential Anti-Cancer Agents Via In Silico Design, Supported by In Vitro and Cell-Based Testing. Current Medicinal Chemistry. 20(10). 1203–1217. 12 indexed citations
13.
Jiang, Xiaoyan, Donna L. Forrest, Franck E. Nicolini, et al.. (2010). Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate. Blood. 116(12). 2112–2121. 46 indexed citations
14.
Shen, Yuh‐Chiang, Chun Guang Li, Shufeng Zhou, et al.. (2008). Chemistry and Bioactivity of Flos Magnoliae, A Chinese Herb for Rhinitis and Sinusitis. Current Medicinal Chemistry. 15(16). 1616–1627. 59 indexed citations
15.
Ringrose, Ashley, Youwen Zhou, Emily M. Pang, et al.. (2006). Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas. Leukemia. 20(9). 1593–1601. 26 indexed citations
16.
Eisterer, Wolfgang, Xiaoyan Jiang, Oliver Christ, et al.. (2005). Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease. Leukemia. 19(3). 435–441. 104 indexed citations
20.
Jiang, Xiaoyan, Yun Zhao, Suzanne Vercauteren, et al.. (2004). Deregulated expression in Ph+ human leukemias of AHI-1, a gene activated by insertional mutagenesis in mouse models of leukemia. Blood. 103(10). 3897–3904. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026